S. Boehnlein Glenn's most recent trade in Inogen Inc was a trade of 30,612 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 30,612 | 76,885 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 374.22 per share. | 21 Mar 2025 | 6,720 | 11,638 (0%) | 0% | 374.2 | 2,514,758 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 314 | 18,358 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2025 | 314 | 0 | - | - | Dividend Equivalents | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 12,916 | 18,044 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.51 per share. | 31 Dec 2024 | 300 | 5,331 (0%) | 0% | 122.5 | 36,753 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 300 | 9,015 | - | - | Employee Stock Option granted 2/8/2017 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 362.26 per share. | 31 Dec 2024 | 203 | 5,128 (0%) | 0% | 362.3 | 73,539 | Common Stock |
| Stryker | Glenn Boehnlein S. | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.51 per share. | 27 Dec 2024 | 2,000 | 6,373 (0%) | 0% | 122.5 | 245,020 | Common Stock |
| Stryker | Boehnlein Glenn S. | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 2,000 | 9,315 | - | - | Employee Stock Option granted 2/8/2017 (right to buy) | |
| Stryker | S. Glenn Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 369.42 per share. | 27 Dec 2024 | 1,342 | 5,031 (0%) | 0% | 369.4 | 495,762 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 4,500 | 11,315 | - | - | Employee Stock Option granted 2/8/2017 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.51 per share. | 18 Nov 2024 | 4,500 | 7,352 (0%) | 0% | 122.5 | 551,295 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 390.08 per share. | 18 Nov 2024 | 2,979 | 4,373 (0%) | 0% | 390.1 | 1,162,048 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 333.00 per share. | 02 Aug 2024 | 20,000 | 2,852 (0%) | 0% | 333 | 6,660,000 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2024 | 25,000 | 15,815 | - | - | Employee Stock Option granted 2/8/2017 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 122.51 per share. | 02 Jul 2024 | 25,000 | 40,012 (0%) | 0% | 122.5 | 3,062,750 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 336.50 per share. | 02 Jul 2024 | 17,160 | 22,852 (0%) | 0% | 336.5 | 5,774,340 | Common Stock |
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 21,871 | 46,273 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 327.65 per share. | 15 May 2024 | 10,000 | 15,012 (0%) | 0% | 327.7 | 3,276,516 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 336.50 per share. | 01 May 2024 | 585 | 25,012 (0%) | 0% | 336.5 | 196,853 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 353.19 per share. | 21 Mar 2024 | 5,555 | 25,597 (0%) | 0% | 353.2 | 1,961,970 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 256 | 31,152 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 256 | 0 | - | - | Dividend Equivalents | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 10,702 | 30,896 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn Boehnlein S. | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 342.81 per share. | 09 Feb 2024 | 9,600 | 20,194 (0%) | 0% | 342.8 | 3,290,952 | Common Stock |
| Stryker | Glenn Boehnlein S. | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 21,190 | 21,190 | - | - | Employee Stock Option granted 02/07/2024 (right to buy) | |
| Stryker | Boehnlein Glenn S. | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 96.64 per share. | 11 Jan 2024 | 49,150 | 68,981 (0%) | 0% | 96.6 | 4,749,856 | Common Stock |
| Stryker | S. Boehnlein Glenn | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 49,150 | 0 | - | - | Employee Stock Option granted 02/10/2016 (right to buy) | |
| Stryker | S. Glenn Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 307.78 per share. | 11 Jan 2024 | 39,187 | 29,794 (0%) | 0% | 307.8 | 12,060,975 | Common Stock |
| Stryker | Glenn Boehnlein S. | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 10,855 | 0 | - | - | Employee Stock Option granted 02/11/2015 (right to buy) | |
| Stryker | S. Boehnlein Glenn | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.06 per share. | 11 Jan 2024 | 10,855 | 19,831 (0%) | 0% | 93.1 | 1,010,166 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 11,955 | 0 | - | - | Employee Stock Option granted 02/12/2014 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.14 per share. | 27 Nov 2023 | 11,955 | 16,570 (0%) | 0% | 81.1 | 970,029 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.64 per share. | 27 Nov 2023 | 7,594 | 8,976 (0%) | 0% | 293.6 | 2,229,902 | Common Stock |
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 17,094 | 24,402 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 299.65 per share. | 01 May 2023 | 572 | 4,615 (0%) | 0% | 299.7 | 171,400 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.83 per share. | 21 Mar 2023 | 2,715 | 5,187 (0%) | 0% | 276.8 | 751,593 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 149 | 7,902 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2023 | 149 | 0 | - | - | Dividend Equivalents | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 5,325 | 7,753 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 30,570 | 30,570 | - | - | Employee Stock Option granted 02/09/2023 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 279.52 per share. | 02 Feb 2023 | 8,883 | 2,553 (0%) | 0% | 279.5 | 2,482,968 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 277.55 per share. | 02 Feb 2023 | 7,709 | 19,144 (0%) | 0% | 277.6 | 2,139,667 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 278.38 per share. | 02 Feb 2023 | 7,708 | 11,436 (0%) | 0% | 278.4 | 2,145,725 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 279.96 per share. | 02 Feb 2023 | 125 | 2,428 (0%) | 0% | 280.0 | 34,995 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.01 per share. | 11 Jan 2023 | 14,515 | 35,286 (0%) | 0% | 64.0 | 929,105 | Common Stock |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2023 | 14,515 | 0 | - | - | Employee Stock Option granted 02/13/2013 (right to buy) | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.81 per share. | 11 Jan 2023 | 8,433 | 26,853 (0%) | 0% | 263.8 | 2,224,710 | Common Stock |
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 6,849 | 7,308 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 01 May 2022 | 1,210 | 18,922 (0%) | 0% | 0 | Common Stock | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 01 May 2022 | 1,210 | 2,421 | - | - | Restricted Stock Units granted 05/04/2021 | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 01 May 2022 | 572 | 18,350 (0%) | 0% | 241.3 | 138,001 | Common Stock | |
| Inogen Inc | Glenn S. Boehnlein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 459 | 459 (0%) | 0% | 0 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 04 Mar 2022 | 8,723 | 0 | - | - | 2019 Performance Stock Units | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 04 Mar 2022 | 8,723 | 21,828 (0%) | 0% | 0 | Common Stock | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 04 Mar 2022 | 8,497 | 8,497 | - | - | 2019 Performance Stock Units | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 04 Mar 2022 | 4,116 | 17,712 (0%) | 0% | 267.3 | 1,100,371 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 02 Feb 2022 | 37,210 | 37,210 | - | - | Employee Stock Option granted 02/02/2022 (right to buy) | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 21 Dec 2021 | 170 | 13,275 (0%) | 0% | 0 | Common Stock | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 21 Dec 2021 | 170 | 13,105 (0%) | 0% | 247.8 | 42,121 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 21 Dec 2021 | 170 | 3,631 | - | - | Restricted Stock Units granted 05/04/2021 | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 10 Dec 2021 | 1,757 | 13,679 (0%) | 0% | 259.7 | 456,251 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 10 Dec 2021 | 574 | 13,105 (0%) | 0% | 260.8 | 149,690 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 10 Dec 2021 | 447 | 15,436 (0%) | 0% | 259.0 | 115,765 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 04 May 2021 | 3,801 | 3,801 | - | - | Restricted Stock Units granted 05/04/2021 | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 21 Mar 2021 | 6,401 | 18,722 (0%) | 0% | 0 | Common Stock | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 21 Mar 2021 | 2,839 | 15,883 (0%) | 0% | 230 | 652,970 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 01 Mar 2021 | 2,000 | 12,321 (0%) | 0% | 246.0 | 492,028 | Common Stock | |
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 03 Feb 2021 | 36,150 | 36,150 | - | - | Employee Stock Option granted 02/03/2021 (right to buy) | ||
| Stryker | Glenn S. Boehnlein | VP, Chief Financial Officer | 28 Dec 2020 | 2,000 | 14,321 (0%) | 0% | 239.1 | 478,209 | Common Stock |